Aurinia Pharmaceuticals Inc. (AUPH) 8-K Summary

This 8-K filing, dated November 4, 2025, formally announces the release of Aurinia’s financial results for the third quarter ended September 30, 2025.

• Material Event: Reporting Item 2.02 (Results of Operations and Financial Condition).
• Key Documents: Detailed metrics are contained in Exhibit 99.1 (Earnings Release) and Exhibit 99.2 (Q3 2025 Update).
• Note: This Form 8-K itself only references the release of the data; actual financial figures and guidance require reviewing the attached exhibits.
• **Executive Sig